Medicine & Life Sciences
Cytomegalovirus
100%
Transplant Recipients
90%
Transplants
68%
Cytomegalovirus Infections
63%
Hematologic Neoplasms
55%
maribavir
46%
Pseudomonas Infections
44%
Pseudomonas aeruginosa
42%
isavuconazole
38%
Hematopoietic Stem Cells
37%
Infections
33%
tazobactam drug combination ceftolozane
25%
Cell Transplantation
24%
Foscarnet
24%
Ganciclovir
21%
Antiviral Agents
21%
Meropenem
20%
Phosphotransferases
19%
AIC246
19%
Carbapenems
18%
Invasive Fungal Infections
17%
Fluoroquinolones
16%
Mutation
16%
WCK 5222
16%
Hematopoietic Stem Cell Transplantation
16%
Transplantation
13%
Respiratory Tract Diseases
12%
Caspofungin
12%
Double-Stranded RNA
11%
Peripheral Blood Stem Cells
11%
Viruses
11%
Therapeutics
11%
Coronavirus Infections
10%
Bacteremia
10%
Serology
10%
Red Cross
10%
Graft vs Host Disease
10%
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9%
Immune Reconstitution
9%
Waste Water
9%
Pharmaceutical Preparations
9%
Mortality
9%
posaconazole
9%
Bronchoalveolar Lavage Fluid
9%
Salvage Therapy
8%
Retinoblastoma
8%
Cyclin-Dependent Kinases
8%
Toxoplasmosis
8%
Phosphoprotein Phosphatases
8%
Voriconazole
8%
Agriculture & Biology
Human betaherpesvirus 5
41%
double-stranded RNA
12%
Cytomegalovirus
10%
infection
8%
nuclear proteins
8%
virus replication
8%
Pseudomonas aeruginosa
7%
phosphotransferases (kinases)
7%
protein kinases
7%
blood flow
7%
codons
7%
translation (genetics)
6%
Vaccinia virus
5%
phosphorylation
5%